Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds

Prospective, Multicentre, Not Controlled Clinical Study to Investigate Efficacy and Tolerability of the Hyaluronic Acid Filler IMD1 Basic After Single Bilateral Injection for Correction of Nasolabial Folds (NLF)

Volunteers receive one injection IMD1 basic of correction of nasolabial folds and are followed-up for up to 36 weeks.

Inclusion Criteria:

• main inclusion criteria: severity rating scale grade 3 or 4

Exclusion Criteria:

• main exclusion criterion: other nasolabial fold corrections within 6 months prior to study entry